{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:02:39Z","timestamp":1784674959605,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-06109-5","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:33:09Z","timestamp":1779373989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complete remission following targeted therapy in BRAF V600E: mutant pulmonary lymphangitic carcinomatosis secondary to rectal cancer\u2014a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0680-9406","authenticated-orcid":false,"given":"Thi Thu Trang","family":"Dao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thu Hien","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huu Loc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Tung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Dung","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Phuong","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Ngan","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu Duy","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Gyu","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Son Hai","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"6109_CR1","unstructured":"Sumant N. Mantri. AKA. Lymphangitic carcinomatosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570633\/."},{"issue":"3","key":"6109_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5152\/TurkThoracJ.2017.16052","volume":"18","author":"M A\u011fca","year":"2017","unstructured":"A\u011fca M, Aky\u0131l FT, H\u00f6rmet M, Akman O, Akman C, \u015een A, et al. A rare case of progressive dyspnea and bilateral lung infiltration in a young male. Turk Thorac J. 2017;18(3):96\u20139.","journal-title":"Turk Thorac J"},{"issue":"5","key":"6109_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/00325481.2019.1595982","volume":"131","author":"M Klimek","year":"2019","unstructured":"Klimek M. Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018. Postgrad Med. 2019;131(5):309\u201318.","journal-title":"Postgrad Med"},{"issue":"15","key":"6109_CR4","doi-asserted-by":"publisher","first-page":"e21064","DOI":"10.1200\/JCO.2021.39.15_suppl.e21064","volume":"39","author":"S Fang","year":"2021","unstructured":"Fang S, Cheng W, Zhang Y, Zhang H, Li S, Xiao M. Successful treatment of pulmonary lymphangitic carcinomatosis by anlotinib in 14 Chinese patients with advanced non-small cell lung cancer. J Clin Oncol. 2021;39(15):e21064\u2013e21064.","journal-title":"J Clin Oncol"},{"issue":"2","key":"6109_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.tjog.2022.02.024","volume":"61","author":"MS Kim","year":"2022","unstructured":"Kim MS, Jeong SY, Lee YY, Choi CH, Kim TJ, Kim BG, et al. Clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: a single-institution experience. Taiwan J Obstet Gynecol. 2022;61(2):333\u20138.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"4","key":"6109_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1200\/JCO.20.02088","volume":"39","author":"J Tabernero","year":"2021","unstructured":"Tabernero J, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, et al. Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E\u2013mutant metastatic colorectal cancer: updated survival results and subgroup analyses from the BEACON study. J Clin Oncol. 2021;39(4):273\u201384.","journal-title":"J Clin Oncol"},{"issue":"4","key":"6109_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1158\/2159-8290.CD-17-1226","volume":"8","author":"RB Corcoran","year":"2018","unstructured":"Corcoran RB, Andr\u00e9 T, Atreya CE, Schellens JHM, Yoshino T, Bendell JC, et al. Combined BRAF, EGFR, and MEK inhibition in patients with BRAF V600E-mutant colorectal cancer. Cancer Discov. 2018;8(4):428\u201343.","journal-title":"Cancer Discov"},{"issue":"5","key":"6109_CR8","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.21037\/jgo-22-748","volume":"13","author":"HX Li","year":"2022","unstructured":"Li HX, Zhang XL, Zhang JQ, Cai M, Li SW. Three-target treatment combined with surgery for BRAF V600E-mutant colon cancer with peritoneal metastasis: a case report. J Gastrointest Oncol. 2022;13(5):2647\u201353.","journal-title":"J Gastrointest Oncol"},{"key":"6109_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1166545","volume":"13","author":"G Piringer","year":"2023","unstructured":"Piringer G, Decker J, Trommet V, K\u00fchr T, Heibl S, D\u00f6rfler K, et al. Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAFV600E mutated, microsatellite-stable colon cancer: a case report and literature review. Front Oncol. 2023;13: 1166545.","journal-title":"Front Oncol"},{"key":"6109_CR10","doi-asserted-by":"crossref","unstructured":"Vaideeswar P, Fernandes G, Datar S, Zare P. Pulmonary lymphangitic carcinomatosis-An experience at autopsy. Indian J Pathol Microbiol. 2024.","DOI":"10.4103\/ijpm.ijpm_1004_22"},{"issue":"1","key":"6109_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2967\/jnumed.119.229575","volume":"61","author":"M Jreige","year":"2020","unstructured":"Jreige M, Dunet V, Letovanec I, Prior JO, Meuli RA, Beigelman-Aubry C, et al. Pulmonary lymphangitic carcinomatosis: diagnostic performance of high-resolution CT and 18F-FDG PET\/CT in correlation with clinical pathologic outcome. J Nucl Med. 2020;61(1):26\u201332.","journal-title":"J Nucl Med"},{"issue":"13","key":"6109_CR12","first-page":"1626","volume":"15","author":"F Dondi","year":"2025","unstructured":"Dondi F, Bellini P, Cossandi M, Camoni L, Rinaldi R, Vigan\u00f2 GL, et al. The role of [18F]FDG PET imaging for the assessment of pulmonary lymphangitic carcinomatosis: a comprehensive narrative literature review. Diagn Basel Switz. 2025;15(13):1626.","journal-title":"Diagn Basel Switz"},{"issue":"6","key":"6109_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/BF02626789","volume":"24","author":"LG Phillips","year":"1981","unstructured":"Phillips LG. Polyposis and carcinoma of the small bowel and familial colonic polyposis. Dis Colon Rectum. 1981;24(6):478\u201381.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"6109_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1378\/chest.105.1.308","volume":"105","author":"S Shimura","year":"1994","unstructured":"Shimura S, Takishima T. Bronchorrhea from diffuse lymphangitic metastasis of colon carcinoma to the lung. Chest. 1994;105(1):308\u201310.","journal-title":"Chest"},{"issue":"4","key":"6109_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1503\/cmaj.080142","volume":"179","author":"A Thomas","year":"2008","unstructured":"Thomas A, Lenox R. Pulmonary lymphangitic carcinomatosis as a primary manifestation of colon cancer in a young adult. CMAJ. 2008;179(4):338\u201340.","journal-title":"CMAJ"},{"issue":"20","key":"6109_CR16","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.2169\/internalmedicine.50.5170","volume":"50","author":"K Otsubo","year":"2011","unstructured":"Otsubo K, Kubo N, Nakashima N, Izumi M, Nakamori M, Koto H. A juvenile case of pulmonary lymphangitic carcinomatosis caused by sigmoid colon cancer with a component of micropapillary carcinoma. Intern Med. 2011;50(20):2361\u20135.","journal-title":"Intern Med"},{"key":"6109_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amsu.2016.01.024","volume":"6","author":"PK Jinnur","year":"2016","unstructured":"Jinnur PK, Pannu BS, Boland JM, Iyer VN. Occult pulmonary lymphangitic carcinomatosis presenting as \u2018chronic cough\u2019 with a normal HRCT chest. Ann Med Surg. 2016;6:77\u201380.","journal-title":"Ann Med Surg"},{"issue":"8","key":"6109_CR18","first-page":"483","volume":"80","author":"M Del Rosario","year":"2016","unstructured":"Del Rosario M, Tsai H, Dasanu CA. Prolonged survival in colon cancer with malignant pericardial effusion and pulmonary lymphangitic carcinomatosis: a case for monoclonal antibodies. Conn Med. 2016;80(8):483\u20135.","journal-title":"Conn Med"},{"issue":"41","key":"6109_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017446","volume":"98","author":"Y Wang","year":"2019","unstructured":"Wang Y, Su M, Li L. Pulmonary lymphangitic carcinomatosis without concurrent liver metastasis from colon cancer detected using 18F-FDG PET\/CT: a case report. Medicine (Baltimore). 2019;98(41): e17446.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"6109_CR20","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.4251\/wjgo.v13.i12.2129","volume":"13","author":"J Zhi","year":"2021","unstructured":"Zhi J, Jia XJ, Yan J, Wang HC, Feng B, Xing HY, et al. BRAFV600E mutant colorectal cancer cells mediate local immunosuppressive microenvironment through exosomal long noncoding RNAs. World J Gastrointest Oncol. 2021;13(12):2129\u201348.","journal-title":"World J Gastrointest Oncol"},{"key":"6109_CR21","doi-asserted-by":"publisher","first-page":"S242","DOI":"10.1016\/j.annonc.2020.04.080","volume":"31","author":"A Grothey","year":"2020","unstructured":"Grothey A, Tabernero J, Taieb J, Yaeger R, Yoshino T, Maiello E, et al. LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer. Ann Oncol. 2020;31:S242\u20133.","journal-title":"Ann Oncol"},{"issue":"3","key":"6109_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41591-024-03443-3","volume":"31","author":"S Kopetz","year":"2025","unstructured":"Kopetz S, Yoshino T, Van Cutsem E, Eng C, Kim TW, Wasan HS, et al. Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial. Nat Med. 2025;31(3):901\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"6109_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.36401\/JIPO-24-16","volume":"8","author":"DA Fox","year":"2025","unstructured":"Fox DA, Bhamidipati D, Kopetz S, Hong DS. Durable remission after targeted therapy in BRAF V600E\u2013 mutant metastatic colorectal cancer: case report. J Immunother Precis Oncol. 2025;8(1):11\u20134.","journal-title":"J Immunother Precis Oncol"},{"key":"6109_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.693655","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang X, Wang G, Cui X. Triple combination therapy with PD-1\/PD-L1, BRAF, and MEK inhibitor for stage III-IV melanoma: a systematic review and meta-analysis. Front Oncol. 2021;11: 693655.","journal-title":"Front Oncol"},{"issue":"5","key":"6109_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00262-025-04005-3","volume":"74","author":"E Tak","year":"2025","unstructured":"Tak E, An HI, Lee AS, Han K, Choi J, Kim HD, et al. Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer. Cancer Immunol Immunother. 2025;74(5):154.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"6109_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41591-022-02181-8","volume":"29","author":"J Tian","year":"2023","unstructured":"Tian J, Chen JH, Chao SX, Pelka K, Giannakis M, Hess J, et al. Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial. Nat Med. 2023;29(2):458\u201366.","journal-title":"Nat Med"},{"key":"6109_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ejca.2020.03.025","volume":"132","author":"F Facchinetti","year":"2020","unstructured":"Facchinetti F, Lacroix L, Mezquita L, Scoazec JY, Loriot Y, Tselikas L, et al. Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non\u2013small cell lung cancer. Eur J Cancer. 2020;132:211\u201323.","journal-title":"Eur J Cancer"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06109-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06109-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06109-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:43:16Z","timestamp":1784673796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06109-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6109"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06109-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee in Biomedical Research of Vinmec International General Hospital Joint Stock Company\u2014VinUniversity (approval number: 61\/2026\/CN\/H\u0110\u0110\u0110 VMEC). Written informed consent was obtained from the patient for participation of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare no conflict of interest.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"412"}}